Moderna Inc said it has partnered with contract drugmaker Catalent Inc to produce 100 million doses of its experimental COVID-19 vaccine starting in the third quarter of 2020.
Under the deal, Catalent would also provide packaging and labeling, storage and distribution services to support Moderna’s late-stage clinical trial for the vaccine.
Via Reuters
